Back to my company list

Illumigyn

The AI engine Fit Assessment

Beta

Illumigyn develops a compact imaging device that enhances cervical examinations by providing high-resolution images and multispectral illumination. Their technology aims to improve diagnostic accuracy and reduce misdiagnoses in gynecological care.

Blurb

Illumigyn incorporates existing machine vision technologies into a compact imaging colposcope for medical applications.

HQ Location

Israel

Founded

2012

Employees

26

Total funding raised

$33.00M

Last Funding Event

Venture - Series Unknown, $33.00M, November 3, 2021

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
  • Health Information Systems
  • Artificial Intelligence in Women's Health Care

Developer of a compact imaging colposcope designed to eliminate the subjectivity of cervical cancer exams. The company's colposcope is based on a medical application that delivers down to micron image resolution and has multispectral illumination options to reduce the subjectivity of machine vision technologies, enabling doctors with sophisticated imaging along with simultaneous complex interventional procedures to assist the best clinical outcomes.